帕金森病自体细胞治疗又迈进一步。
A step closer to autologous cell therapy for Parkinson's disease.
机构信息
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, MA 02114, USA.
Institute for Translational Brain Research, Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, 200032, China.
出版信息
Cell Stem Cell. 2021 Apr 1;28(4):595-597. doi: 10.1016/j.stem.2021.03.010.
PMID:33798419
Abstract
In a recent report in Nature Medicine, Tao et al. (2021) demonstrate that MPTP-treated monkeys receiving autologous, but not allogeneic, transplantation showed significant long-term improvement in motor and depressive behaviors, supporting the feasibility of autologous cell therapy for Parkinson's disease (PD).
摘要
在《自然医学》的一篇最新报告中，Tao 等人（2021 年）证明，接受自体而非异体移植的 MPTP 处理猴子在运动和抑郁行为方面表现出显著的长期改善，这支持了自体细胞疗法治疗帕金森病（PD）的可行性。
Zotero 插件